Cargando…
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project
Autores principales: | Rüschoff, Jan Hendrik, Haberecker, Martina, Tsourti, Zoi, Nackaerts, Kristiaan, de Perrot, Marc, Brcic, Luka, Nadal, Ernest, Tsimpoukis, Sotirios, Gray, Steven G., Ampollini, Luca, Aerts, Joachim G., Felley-Bosco, Emanuela, Kirschner, Michaela B., Monkhorst, Kim, Weynand, Birgit, Bavaghar-Zaeimi, Fatemeh, Samarzija, Miroslav, Llatjos, Roger, Finn, Stephen P., Silini, Enrico, von der Thüsen, Jan, Marti, Nesa, Vervita, Karerina, Kammler, Roswitha, Peters, Solange, Stahel, Rolf A., Baas, Paul, Opitz, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708548/ https://www.ncbi.nlm.nih.gov/pubmed/36253399 http://dx.doi.org/10.1038/s41379-022-01170-z |
Ejemplares similares
-
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project
por: Rüschoff, Jan Hendrik, et al.
Publicado: (2022) -
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial
por: Girard, N., et al.
Publicado: (2023) -
Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation
por: Annemans, Lieven, et al.
Publicado: (2015) -
Counting asbestos bodies in bronchoalveolar lavage: trend analysis and a systematic review
por: Nuyts, Valerie, et al.
Publicado: (2015) -
Pembrolizumab-induced necrotizing myositis in a patient with metastatic non-small-cell lung cancer: a case report
por: Claus, Jonas, et al.
Publicado: (2019)